Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Charles River-WuXi PharmaTech Deal Transforms China's CRO Landscape

Apr 28 2010

• By PharmAsia News

Related Content

Shanghai ChemPartner CEO Michael Hui On Finding A Niche In China Amidst Increasing Foreign Competition: An Interview With PharmAsia News (Part 1 of 2)

Apr 14 2008

Covance To Open Its Own Preclinical Facility In Shanghai After Abandoning Plans To Create Joint Drug Testing Facility With WuXi

Feb 08 2010

PPD Continues High-speed Expansion In Asia With Second Acquisition Of A China-based CRO This Quarter

Nov 20 2009

Charles River To Merge With Leading Chinese Drug CRO WuXi PharmaTech If $1.6 Billion Transaction Is Approved By Beijing's Antitrust Czars

Apr 26 2010

Wuxi PharmaTech Obtains Humane Animal Treatment Accreditation For Toxicology Facility In Eastern China

Mar 01 2010

More from Archive

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window